Background: Availability of portable and home-based electrocardiography (ECG) is
potential to enhance utility of this technique in out-of-hospital settings such as within households, endurance trainings, sports training, and public places. It is also possible to immediately transmit obtained waveforms for expert interpretation, in addition to already available computerized reports. 6, 7 Many such sensors are wearable, small in size, and can be used to monitor rhythms and waveforms over weeks or months. 8 Many handheld ECG devices give only limited information as compared to conventional 12-lead ECGs. Hence, concerns about their accuracy and reliability need to be examined. As information obtained by ECG invariably needs to be interpreted along with clinical inputs, it is debated if out-of-hospital use will really be beneficial. More visits to a hospital because of a false-positive test, and missed opportunities because of false negatives will always be a concern as this technology expands.
We performed this review to understand the current state of out-of-hospital electrocardiography technologies with respect to diagnostic accuracy and utility. Diagnostic accuracy of the devices is represented in Table 1 and utility (pros and cons) in Table 2 . To distinguish this technology from conventional electrocardiography that could have been performed in an out-of-hospital setting, we focused only on portable, handheld, or wearable devices.
| ME TH ODS
We used multiple overlapping data sources for this review. We performed PubMed and Internet searches for "handheld" or "wearable"
or "patch" electrocardiography devices to enlist available technologies. We also searched PubMed with names of individual devices to obtain additional citations. We sought to include only those devices that were commercially available. Information about many devices was available only from the manufacturer, and for others from manufacturer and the PubMed citations. We classified available devices as a "single limb lead ECG recording devices" if they used fingers or thumb of both hands for capture. These devices typically used a touch sensation of fingers, thumb, wrist, or palm to capture electrical signals. Devices that could capture two or more ECG leads used sensors placed on the chest wall. These were classified as chest-lead "ECG recording devices." The sensors may have been embedded in a wearable patch, belt, or a card were so identified. We used the term electrode for a device that used wires to transmit the electric signal from the chest wall to the sensing device, as in conventional electrocardiography. If a device used more than three electrodes, it was defined as either a conventional electrocardiography or Holter machine and was excluded from this review. We also excluded devices that only analyzed the regularity of the pulse, without evaluating electrocardiograph.
| RESULTS
We identified a total of 15 devices, 12 of these were single limb lead ECG recording devices and remaining 3 were chest-lead ECG recording devices. Overall, only six of these devices (five single lead and one chest lead) featured in published medical literature as identified from PubMed search (Table 1) . A total of 13 citations were available for the single limb lead ECG recording devices and 6 citations for the chest-lead ECG recording devices. The devices that have been evaluated for their accuracy, reproducibility, or utility are described in the following sections. Pros and cons of each device are described in Table 2 . Figure 1 
| Multiple-lead ECG devices

| ZioPatch
The ZioPatch is a 14-day, ambulatory ECG monitoring adhesive patch applied over the left pectoral region of patient's chest. It is a 3-lead ECG device, water resistant, wireless patch that requires no battery charging. After wearing the patch for prescribed period of time, the data are analyzed from the ZioPatch.
The utility of ZioPatch has been demonstrated in various studies. In a large study by Turakhia MP et al 23 it was found that compared with first 48 hours of monitoring, the overall diagnostic yield was greater when data from the entire ZioPatch wear duration were included for any arrhythmia (P < .0001) and for any symptomatic arrhythmia (P < .0001). In another study by Barrett PM et al 24 it was shown that adhesive patch monitor detected more arrhythmia events compared with the Holter monitor over the total wear time (P < .001), although the Holter monitor detected more events during the initial 24-h monitoring period 
| DISCUSSION
Of a total of 15 devices identified in our review, only 6 have been evaluated and published in biomedical literature. Despite a limited number of publications, sufficient literature exists to prove the concept and utility of such devices. There is a heterogeneity in terms of ter than a single-lead device in this regard, but interpretation of the presence or absence of ischemia will still be uncertain as compared to a 12-lead ECG. In a recent study, clinic-based triage in acute coronary syndrome was better than ECG-based triage. 34 Multiple chest-lead wearable devices however will have an unparalleled utility in diagnosis of stable angina, when individuals have chest pain or equivalent symptoms on exertion. There could be a potential to supplant exercise-electrocardiography in these situations. 
T A B L E 2 Pros and cons of all commercially available devices in this review
| CONCLUSION
